This profile has not been claimed and data may not be accurate.
Founder246
68th percentile
Investor113
96th percentile
Serial FounderUnicorn FounderIPORaised $100M+1,000+ EmployeesAngel InvestorOn Wikipedia
Founder Matrix
Most Like You
Most Complimentary
Credibility
this founder typical founder (50th pct)
Domain Expertise · 91th percentile
- Wikipedia page exists for Fred Ehrsam, confirming notable public presence.
Founder score
- 99%Probability of being accurate (99%)Coinbase reached a $17B market cap as a public company, confirming Fred Ehrsam as a unicorn founder.
- 99%Probability of being accurate (99%)Coinbase went public via IPO in 2021, representing a successful exit from a company Fred co-founded.
- 99%Probability of being accurate (99%)Past co-founder of Coinbase, the largest U.S. cryptocurrency exchange, where he served as President from 2012 to 2017.
- 99%Probability of being accurate (99%)Wikipedia page exists for Fred Ehrsam, confirming notable public presence.
- 97%Probability of being accurate (97%)Paradigm (paradigm.xyz, Majestic Million rank 52,382) is a company Fred co-founded.
- 97%Probability of being accurate (97%)Current founder and CEO of Nudge, a neurotechnology company building non-invasive brain-computer interfaces.
- 95%Probability of being accurate (95%)Nudge raised $100M in a Series A led by Thrive Capital and Greenoaks.
- 95%Probability of being accurate (95%)Nudge has multiple co-founders including Jeremy Barenholtz and Quintin Frerichs alongside Fred Ehrsam.
Investor score
- 99%Probability of being accurate (99%)Partner and General Partner at Paradigm, a recognized crypto-focused venture capital firm with a public deal record.
- 99%Probability of being accurate (99%)Active GP and co-founder of Paradigm, a crypto-focused venture capital fund he co-runs.
- 97%Probability of being accurate (97%)Coinbase, a portfolio company Fred co-founded and where Paradigm invested, went public via IPO in 2021.
- 95%Probability of being accurate (95%)Paradigm was founded in 2018, giving Fred approximately 7 years of investing experience as a fund manager.
- 85%Probability of being accurate (85%)Publicly identified as an angel investor who occasionally invests when the opportunity is right.
- 75%Probability of being accurate (75%)Paradigm has backed many category-defining protocols and companies in the crypto space, with a broad active portfolio.
What you likely need
Fred Ehrsam is a serial founder and elite crypto investor with three major company co-foundings (Coinbase, Paradigm, Nudge), a successful IPO exit, and a $100M Series A already closed at Nudge. His primary focus right now is scaling Nudge from early research into a clinical-stage neurotechnology company while maintaining his GP role at Paradigm. The biggest leverage points are talent density, scientific credibility, and regulatory navigation for a novel medical device.
Are these your current priorities?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- hiringAggressively recruit top computational neuroscientists and ultrasound engineers — Nudge's competitive moat is scientific talent, and the $100M Series A gives you the runway to compete with academic labs on compensation.
- tacticalEngage the FDA early via a Pre-Submission meeting to map the regulatory pathway for your focused-ultrasound neuromodulation device before pivoting from research studies to clinical trials.
- introsLeverage your Coinbase board seat and Paradigm LP network to recruit high-net-worth angels and strategic advisors from the biotech and medtech world who can open hospital and IRB relationships.
- positioningPublish peer-reviewed results from your Nudge Zero human studies in a top neuroscience journal to establish scientific credibility and differentiate from the crowded BCI hype cycle.
- fundraisingBegin Series B preparation now by defining clear clinical milestones (e.g., first IRB-approved therapeutic indication) that will anchor the next round narrative for crossover healthcare investors.
- positioningClarify your public role at Paradigm — stepping down as Managing Partner while remaining GP creates ambiguity; a clear 'Senior Advisor' or 'Founding GP' title will help LPs and co-investors understand your bandwidth.
- wellbeingRunning a deep-tech biotech startup while maintaining a GP role at a major crypto fund is an unusually high cognitive load — deliberately protect time for recovery and strategic thinking to avoid decision fatigue.